Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

Mina Gendy, DO, Marie Anne Christine Buteau, MD, Marc Braunstein, MD PhD

Blood (2019) 134 (Supplement_1): 3655.

https://doi.org/10.1182/blood-2019-131978

Published: 2019

Journal Articles

First Report of Reversible Macrocytic Anemia with Dysplastic Features Associated with Palbociclib Use in Patients with Metastatic Breast Cancer

Tamanna Haque, MD, Jesus Anampa, MD, Irina Murakhovskaya, MD, Yanhua Wang, MD PhD, Kimo Bachiashvili, MD, Cristian Papazoglu, MD PhD, Kith Pradhan, PhD, Ulrich G. Steidl, MDPhD, Amit Verma, MD

Blood (2017) 130 (Supplement 1): 2207.

https://doi.org/10.1182/blood.V130.Suppl_1.2207.2207

Published: 2017

Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens

Blood (2017) 130 (Supplement 1): 5165.

https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165

Published: 2017

Journal Articles

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Archana Thakur, PhD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G. Lum, MD DSC

Blood (2016) 128 (22): 3459.

https://doi.org/10.1182/blood.V128.22.3459.3459

Published: 2016

Journal Articles

Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of Clinical Outcome in 66 Cancer Patients

Blood (2014) 124 (21): 310.

https://doi.org/10.1182/blood.V124.21.310.310

Published: 2014

Journal Articles

Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype

Dusten Unruh, BS, Farah Sagin, BA, Mariette Adam, Patrick Van Dreden, PhD, Barry J Woodhams, PhD, Syed A Ahmad, MD, Vladimir Y Bogdanov, PhD

Blood (2014) 124 (21): 1486.

https://doi.org/10.1182/blood.V124.21.1486.1486

Published: 2014

Journal Articles

Sensitizing shRNA Screen for Molecular Targets in CDK4/CDK6-Based Combination Therapy in Multiple Myeloma

Xiangao Huang, PhD, Maurizio Di Liberto, PhD, David Chiron, PhD, Ruben Niesvizky, MD, Anna C. Schinzel, PhD, William C. Hahn, MD PhD, Selina Chen-Kiang, PhD

Blood (2014) 124 (21): 3440.

https://doi.org/10.1182/blood.V124.21.3440.3440

Published: 2014

Journal Articles

Metastatic Breast Cancer in a Patient with Fanconi Anemia

Jeffrey Graham, MD, Debjani Grenier, MD, Arjuna Ponnampalam, MD

Blood (2014) 124 (21): 5164.

https://doi.org/10.1182/blood.V124.21.5164.5164

Published: 2014

Journal Articles

Predicting Therapy-Related Acute Myeloid Leukemia By Routine Laboratory Values: An Analysis Of 126 Patients With Breast Cancer Referred For Bone Marrow Biopsy At Memorial Sloan-Kettering Cancer Center

Eytan M Stein, MD, Meier Hsu, Adam Goldrich, MD, Ashwin Kishtagari, MBBS, Sean M. Devlin, PhD, Martin S. Tallman, MD, Gerald A. Soff, MD, Rekha Parameswaran, MD

Blood (2013) 122 (21): 2661.

https://doi.org/10.1182/blood.V122.21.2661.2661

Published: 2013

Journal Articles

Spectrum Of Clinical and Laboratory Findings In Adult Patients With Hemophagocytic Lymphohistiocytosis: Significance Of Ferritin Levels

Zaher K. Otrock, MD, Charles S. Eby, MD

Blood (2013) 122 (21): 1037.

https://doi.org/10.1182/blood.V122.21.1037.1037

Published: 2013

Journal Articles

Validation Of a Brief Arsenic Trioxide (ATO)-Based Consolidation Chemotherapy In The Upfront Management Of Acute Promyelocytic Leukemia (APL): Less Anthracycline Exposure and Faster Completion Of Consolidation Therapy With Equivalent Survival

Mindy Leech, PharmD, Moshe Stewart, Xu Zhang, PhD, Asad Bashey, MD, PhD, H. Kent Holland, MD, Scott R. Solomon, MD, Hetty E Carraway, MD, MBA, B. Douglas Smith, MD, Lawrence E. Morris, MD, Steven D. Gore, MD, Amer M. Zeidan, MD

Blood (2013) 122 (21): 3963.

https://doi.org/10.1182/blood.V122.21.3963.3963

Published: 2013

Journal Articles

Rosuvastatin Lowers Circulating Tissue Factor Antigen-Bearing Microparticles In Metastatic Breast Cancer: A Phase II, Multi-Dose, Randomized Trial (MicroSTAT Trial)

Jeffrey I. Zwicker, MD, Erica L. Mayer, MD, Federico Campigotto, MS, Julia Geddings, Herold Christina, M.D., Sheryl Bowley, Ph.D., Gerburg Wulf, MD, Gary Horowitz, MD, Donna S. Neuberg, ScD, Nigel Mackman, PhD, Bruce Furie, MD

Blood (2013) 122 (21): 579.

https://doi.org/10.1182/blood.V122.21.579.579

Published: 2013

Journal Articles

Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.

Betty K. Hamilton, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Shawnda Tench, Matt Kalaycio, MD, Steven Andresen, DO, Robert M Dean, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Brian T. Hill, MD, PhD, Rabi Hanna, MD, Hien K. Duong, MD, Edward A. Copelan, MD

Blood (2012) 120 (21): 3072.

https://doi.org/10.1182/blood.V120.21.3072.3072

Published: 2012

Journal Articles

Development of Coagulation Factor Probes for the Identification of Procoagulant Circulating Tumor Cells

Flor A. Cianchetti, PhD, Garth W. Tormoen, MS, Paul E. Bock, PhD, Owen J.T. McCarty, PhD

Blood (2012) 120 (21): 634.

https://doi.org/10.1182/blood.V120.21.634.634

Published: 2012

Journal Articles

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Pray, BS, Elyse N. Tomaszewski, BA, Ritesh Rathore, MD, Patricia A. Steele, RN, BSN, Muneer H. Abidi, MD, Lois Ayash, MD, Dana L Schalk, BS, MBA, Karen Myers, BSN, OCN, Alice Mitchell, BS, Abhinav Deol, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc

Blood (2011) 118 (21): 1914.

https://doi.org/10.1182/blood.V118.21.1914.1914

Published: 2011

Journal Articles

The Novel Plasminogen Receptor, Plg-R KT , and Breast Cancer Progression

Lindsey A Miles, PhD, Nagyung Baik, MS, Stan Krajewski, MD, Robert J Parmer, MD, Barbara M Mueller, Ph.D.

Blood (2011) 118 (21): 853.

https://doi.org/10.1182/blood.V118.21.853.853

Published: 2011

Journal Articles

Fractionated 90 y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Timothy M Illidge, MD, PhD, Ruth Pettengell, MD, Michael Bayne, MD, Steven Le Gouill, MD, PhD, Andrew Bates, MD, John Radford, MD, Jill Tipping, PhD, Maureen Zivanovic, PhD, Françoise kraeber-Bodere, MD, Emmanuel Malek, PhD, Huglo Damien, MD, Franck Morschhauser, MD, PhD

Blood (2011) 118 (21): 102.

https://doi.org/10.1182/blood.V118.21.102.102

Published: 2011

Journal Articles

Recombinant Human Erythropoietin (rHuEPO) In Combination with Chemotherapy Increases Breast Cancer Metastasis In Pre-Clinical Mouse Models

Anargyros Xenocostas, MD, FRCPC, Benjamin D Hedley, PhD, Jenny E Chu, BSc, D. George Ormond, BSc, Michel Beausoleil, MSc, Alexandra Boasie, BSc, Alison L Allan, PhD

Blood (2010) 116 (21): 3345.

https://doi.org/10.1182/blood.V116.21.3345.3345

Published: 2010

Journal Articles

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Ranjana H Advani, MD, Fangxin Hong, Ph.D., Kristen N. Ganjoo, MD, Judith B. Manola, MS, Lode J. Swinnen, MBChB, Thomas M Habermann, MD, Sandra J Horning, MD

Blood (2009) 114 (22): 1671.

https://doi.org/10.1182/blood.V114.22.1671.1671

Published: 2009

Journal Articles

Jamshidi needle Biopsy of the Sternal Bone Marrow.

Enrique Davila, MD

Blood (2009) 114 (22): 4548.

https://doi.org/10.1182/blood.V114.22.4548.4548

Published: 2009

NARROW

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

First Report of Reversible Macrocytic Anemia with Dysplastic Features Associated with Palbociclib Use in Patients with Metastatic Breast Cancer

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of Clinical Outcome in 66 Cancer Patients

Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype

Sensitizing shRNA Screen for Molecular Targets in CDK4/CDK6-Based Combination Therapy in Multiple Myeloma

Metastatic Breast Cancer in a Patient with Fanconi Anemia

Predicting Therapy-Related Acute Myeloid Leukemia By Routine Laboratory Values: An Analysis Of 126 Patients With Breast Cancer Referred For Bone Marrow Biopsy At Memorial Sloan-Kettering Cancer Center

Spectrum Of Clinical and Laboratory Findings In Adult Patients With Hemophagocytic Lymphohistiocytosis: Significance Of Ferritin Levels

Validation Of a Brief Arsenic Trioxide (ATO)-Based Consolidation Chemotherapy In The Upfront Management Of Acute Promyelocytic Leukemia (APL): Less Anthracycline Exposure and Faster Completion Of Consolidation Therapy With Equivalent Survival

Rosuvastatin Lowers Circulating Tissue Factor Antigen-Bearing Microparticles In Metastatic Breast Cancer: A Phase II, Multi-Dose, Randomized Trial (MicroSTAT Trial)

Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.

Development of Coagulation Factor Probes for the Identification of Procoagulant Circulating Tumor Cells

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

The Novel Plasminogen Receptor, Plg-R KT , and Breast Cancer Progression

Fractionated 90 y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Recombinant Human Erythropoietin (rHuEPO) In Combination with Chemotherapy Increases Breast Cancer Metastasis In Pre-Clinical Mouse Models

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Jamshidi needle Biopsy of the Sternal Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only